200 1st Street SW
822 articles with Mayo Clinic
Elysium Health™ Announces Initiation of Phase II Clinical Trial at Mayo Clinic to Evaluate BASIS™ for Prevention of Acute Kidney Injury After Cardiac Surgery
Elysium Health, Inc.,TM a life sciences company developing clinically validated health products based on aging research, announced the initiation of a Phase II clinical trial at Mayo Clinic to evaluate the efficacy of BASISTM for the prevention of acute kidney injury in patients that have undergone a cardiac surgery.
A study recently conducted at Mayo Clinic showed that dysfunctional Tissue Resident Memory (TRM) CD8 T cells are actually working against the elderly, reducing immunity and enabling residual chronic lung issues after respiratory infections such as COVID-19.
Jellagen® Limited, a marine biotechnology business manufacturing high value collagen derived from jellyfish, has entered into a license agreement for an exclusive grant to patent rights with Mayo Clinic for the development in treatment of vocal cord paralysis.
Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) Platform
Sorrento Therapeutics, Inc. announced it has entered into an exclusive license agreement with Mayo Clinic for a potential breakthrough technology platform that is capable of generating a great diversity of stable antibody-drug-nanoparticle albumin-bound immune complexes targeting many types of human diseases including various solid and liquid tumors.
Davis is the voice behind Mayo Clinic's latest creative campaign "You Know Where to Go"
Plakous Therapeutics, Inc. announced that it has signed a know-how license agreement with Mayo Clinic. The multi-year agreement will focus on understanding the results of a natural history study of the factors associated with necrotizing enterocolitis (NEC), a rare disease affecting premature babies. Plakous has received Orphan
Now one of the largest and strongest pediatric cardiovascular programs in the country [18-August-2020] MINNEAPOLIS , Aug. 18, 2020 /PRNewswire/ -- Children's Minnesota and Mayo Clinic announced today that they have reached the next phase of an agreement to collaborate in the care of children with congenital heart disease. This phase of the agreement adds pediatric c
8/17/2020It was a very busy week for clinical trial updates. Here’s a look.
The results from a three-month study in more than 35,000 patients were published yesterday on a preprint server, which means they have not yet been peer-reviewed.
Empire State Realty Trust to Advance Study of Indoor Environmental Quality with Well Living Lab, a Delos and Mayo Clinic Collaboration
Industry leader at forefront of initiative to evaluate methods and establish guidelines to enhance employee performance as organizations navigate their return to offices. ROCHESTER, Minn.--( BUSINESS WIRE )-- The Well Living Lab, a Delos and Mayo Clinic collaboration dedicated to researching the indoor environment’s impact on human health, today announced that Empire State Realty Trust, Inc., a real estate leader, will join the Well Living Lab Allian
In support of Mayo Clinic's digital health and practice transformation initiatives, the Mayo Clinic Department of Laboratory Medicine and Pathology has initiated an enterprise-wide digital pathology implementation of the Sectra digital slide review and image storage and management system to enable digita
Adaptive Phage Therapeutics Enters Agreement with Mayo Clinic to Commercialize a Phage Susceptibility Test
Mayo Clinic and Adaptive Phage Therapeutics (APT) today announced a collaboration to advance and commercialize a phage susceptibility test (PST) linked exclusively to APT’s PhageBank™ investigational therapy. At launch, the PST will be offered as a laboratory developed test for worldwide commercial availability by Mayo Clinic Labo
Mayo Clinic joins Biomerica’s InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial
Biomerica also announces its first Japanese patent has been granted for its InFoods® IBS Diagnostic Guided Therapy technology
Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation
"The Fight Is In Us" Campaign Seeks to Mobilize COVID-19 Survivors to Accelerate the Development of Potentially Lifesaving Therapies [26-May-2020] REDMOND, Wash. and NEW YORK , May 26, 2020 /PRNewswire/ -- A coalition of world-leading medical and research institutions, blood centers, life science companies, technology companies, philanthropic organizations
Combining Current Health’s remote patient management platform with Mayo Clinic’s medical and scientific expertise, the organizations aim to create AI-driven solutions that aid disease understanding and treatment BOSTON--( BUSINESS WIRE )-- Current Health today announced that it has launched a collaboration with Mayo Clinic to develop remote monitoring solutions that accelerate the identification of COVID-19-positive patients and predict symptom an
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 29, 2020.
Methodist Joins Mayo Clinic Convalescent Plasma Protocol In Hopes Of Finding Successful Treatment For COVID-19 Patients
This week, Methodist Le Bonheur Healthcare announced it is participating in Mayo Clinic's Expanded Access Protocol for Convalescent Plasma Program for treatment of patients with COVID-19.
The U.S. Food and Drug Administration approved the first blood test that looks for the antibodies against the novel coronavirus that causes COVID-19.
SyntheticMR announced that they have received a purchase order from Mayo Clinic for its medical imaging software solution SyMRI.
Mayo Clinic's Gregory A. Poland, M.D., is featured expert of "Coronavirus: Exposing Myths from Facts" webinar for charter school leaders
First installment of three-part webinar series hosted by Charter School Capital will address health implications of COVID-19; contingency & communication and financial webinars to follow